| 英文别名： |
4-Hydroxyandrost-4-ene-3,17-dione;Formestane;B, Aromatase inhibitor;(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione;4-Androsten-4-ol-3,17-dione;4-Hydroxy-4-androstene-3,17-dione;4-Hydroxyandrostenedione;4-OHA;4-OH-A;4-OHAD;Acetyl broMide;CGP-32349;Lentaron;roxburgh rose extract powder;Tox21_112111_1;Lentaron Depot;MLS000028826;FORMESTANE [MI];566-48-3;OSVMTWJCGUFAOD-KZQROQTASA-N;Androst-4-ene-3, 4-hydroxy-;SMR000058722;AB00572625-07;FORMESTANE [WHO-DD];FORMESTANE [INN];formestane;MLS002153359;NSC 282175;BCP03066;FORMESTANE [MART.];NCGC00344560-01;Formestane (INN);NCGC00164380-02;NCGC00015070-04;D07260;NS00009015;4-hydroxy-Delta(4)-androstenedione;CAS-566-48-3;CS333;AKOS015895451;BDBM225704;CHEBI:75172;Lentaron (TN);HY-B0697;HMS2234J06;NCGC00164380-01;SR-01000721948;(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-quinone;4-hydroxy-Delta4-androstenedione;Lentaron(R);Tox21_112111;NSC282175;AS-75658;(10R,13S)-4,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione;HMS2090I22;CCG-221077;NCI60_002316;Tox21_302286;NCGC00255321-01;Q3077501;Formestane [INN:BAN];CGP 32349;MFCD00057814;DB08905;BRN 1889793;formestano;ANDROST-4-ENE-3,17-DIONE, 4-HYDROXY-;Tox21_113509;formestanum;HMS3715G16;Opera_ID_865;(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione;PUB9T8T355;Lentaron(R)17-dione;4-oh-androstene-3,17-dione;DTXSID3034113;DTXCID1014113;UNII-PUB9T8T355;SCHEMBL25717;17-dione;s2208;MLS001148070;CCRIS 7483;NSC-282175;A831133;SR-01000721948-2;Formestane, solid;SaveCream;4-Hydroxy-delta(sub 4)-androstenedione;(8R,9S,10R,13S,14S)-10,13-dimethyl-4-oxidanyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione |
沪公网安备31011402010658号 
